Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Xtremity develops a medical device to offer better connection sockets for prosthetics.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug conjugate technology.
Decheng Capital has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Decheng Capital's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Pharmaceutical. The firm invests across 12 different industry categories.
Among tracked funding rounds, Terns Pharmaceuticals received $650.0M in a Post-IPO Equity round. Decheng Capital's total known invested capital is $3.7B.
Decheng Capital's average investment size is $71.9M across its portfolio of 51 companies.
Recent Decheng Capital portfolio additions include Adela, Shape Therapeutics, Everest Medicines, Whitehawk Therapeutics, Equillium. These companies were founded in 2020 or later.